Identification of oligomers at early stages of tau aggregation in Alzheimer's disease

FASEB Journal

Volumn 26, Issue 5, 2012, Pages 1946-1959

  Lasagna Reeves, Cristian A ^a   Castillo Carranza, Diana L ^a   Sengupta, Urmi ^a   Sarmiento, Jose ^a,c   Troncoso, Juan ^b   Jackson, George R ^a   Kayed, Rakez ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

Author keywords

Conformational antibodies; Neurodegeneration; Protein misfolding; Tauopathies

Indexed keywords

OLIGOMER; RECOMBINANT PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANTIBODY SPECIFICITY; ARTICLE; BRAIN; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FRONTAL CORTEX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTENSITY CORRELATION ANALYSIS; NEUROBLASTOMA CELL; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN FOLDING; TAUOPATHY; WESTERN BLOTTING;

ALZHEIMER DISEASE; ANTIBODIES; BIOPOLYMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; FRONTAL LOBE; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION; TAU PROTEINS; UBIQUITINATION;

ANIMALIA;

EID: 84858965241     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-199851     Document Type: Article

References (99)

1. Schultz, C., Ghebremedhin, E., Del Tredici, K., Rub, U., and Braak, H. (2004) High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe. Neurobiol. Aging 25, 397-405 (Pubitemid 38220974)
2. Umahara, T., Tsuchiya, K., Ikeda, K., Kanaya, K., Iwamoto, T., Takasaki, M., Mukai, K., Shibata, N., and Kato, S. (2002) Demonstration and distribution of tau-positive glial coiled body-like structures in white matter and white matter threads in early onset Alzheimer's disease. Neuropathology 22, 9 -12
3. Braak, H., and Braak, E. (1988) Neuropil threads occur in dendrites of tangle-bearing nerve cells. Neuropathol. Appl. Neurobiol. 14, 39-44
4. Adalbert, R., Nogradi, A., Babetto, E., Janeckova, L., Walker, S. A., Kerschensteiner, M., Misgeld, T., and Coleman, M. P. (2009) Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain 132, 402-416
5. Augustinack, J. C., Schneider, A., Mandelkow, E. M., and Hyman, B. T. (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 103, 26-35 (Pubitemid 36075309)
6. Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., and Van Hoesen, G. W. (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1, 103-116
7. Braak, H., and Braak, E. (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82, 239 -259
8. Alonso, A. C., Li, B., Grundke-Iqbal, I., and Iqbal, K. (2008) Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. Curr. Alzheimer. Res. 5, 375-384
9. Lee, V. M., Goedert, M., and Trojanowski, J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159 (Pubitemid 32695256)
10. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A., and Hof, P. R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95-130
11. Goedert, M., Spillantini, M. G., Cairns, N. J., and Crowther, R. A. (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168
12. Matsuo, E. S., Shin, R. W., Billingsley, M. L., Van deVoorde, A., O'Connor, M., Trojanowski, J. Q., and Lee, V. M. (1994) Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 13, 989-1002 (Pubitemid 24347311)
13. Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Watanabe, A., Titani, K., and Ihara, Y. (1995) Hyperphosphorylation of tau in PHF. Neurobiol. Aging 16, 365-371; discussion 371-380
14. Drewes, G., Lichtenberg-Kraag, B., Doring, F., Mandelkow, E. M., Biernat, J., Goris, J., Doree, M., and Mandelkow, E. (1992) Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11, 2131-2138
15. Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J. P., and Anderton, B. H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62
16. Drewes, G., Trinczek, B., Illenberger, S., Biernat, J., Schmitt-Ulms, G., Meyer, H. E., Mandelkow, E. M., and Mandelkow, E. (1995) Microtubule-associated protein/microtubule affinityregulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262. J. Biol. Chem. 270, 7679-7688
17. Baumann, K., Mandelkow, E. M., Biernat, J., Piwnica-Worms, H., and Mandelkow, E. (1993) Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 336, 417-424 (Pubitemid 24036992)
18. Goedert, M., Jakes, R., Qi, Z., Wang, J. H., and Cohen, P. (1995) Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J. Neurochem. 65, 2804-2807
19. Johnson, G. V., and Stoothoff, W. H. (2004) Tau phosphorylation in neuronal cell function and dysfunction. J. Cell Sci. 117, 5721-5729 (Pubitemid 40123939)
20. Chatterjee, S., Sang, T. K., Lawless, G. M., and Jackson, G. R. (2009) Dissociation of tau toxicity and phosphorylation: role of GSK-3β, MARK and Cdk5 in a Drosophila model. Hum. Mol. Genet. 18, 164-177
21. Talmat-Amar, Y., Arribat, Y., Redt-Clouet, C., Feuillette, S., Bouge, A. L., Lecourtois, M., and Parmentier, M. L. (2011) Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila. Hum. Mol. Genet. 20, 3738-3745
22. Reifert, J., Hartung-Cranston, D., and Feinstein, S. C. (2011) Amyloid β-mediated cell death of cultured hippocampal neurons reveals extensive tau fragmentation without increased full-length Tau phosphorylation. J. Biol. Chem. 286, 20797-20811
23. Diaz-Hernandez, M., Gomez-Ramos, A., Rubio, A., Gomez-Villafuertes, R., Naranjo, J. R., Miras-Portugal, M. T., and Avila, J. (2010) Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau. J. Biol. Chem. 285, 32539-32548
24. Andorfer, C., Acker, C. M., Kress, Y., Hof, P. R., Duff, K., and Davies, P. (2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J. Neurosci. 25, 5446-5454 (Pubitemid 40770926)
25. Polydoro, M., Acker, C. M., Duff, K., Castillo, P. E., and Davies, P. (2009) Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J. Neurosci. 29, 10741-10749
26. Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S. M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., and Lee, V. M. (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337-351 (Pubitemid 46161268)
27. Mocanu, M. M., Nissen, A., Eckermann, K., Khlistunova, I., Biernat, J., Drexler, D., Petrova, O., Schonig, K., Bujard, H., Mandelkow, E., Zhou, L., Rune, G., and Mandelkow, E. M. (2008) The potential for β-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 28, 737-748 (Pubitemid 351159036)
28. Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., and Feany, M. B. (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711-714 (Pubitemid 32728676)
29. Paquet, D., Bhat, R., Sydow, A., Mandelkow, E. M., Berg, S., Hellberg, S., Falting, J., Distel, M., Koster, R. W., Schmid, B., and Haass, C. (2009) A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J. Clin. Invest. 119, 1382-1395
30. Berger, Z., Roder, H., Hanna, A., Carlson, A., Rangachari, V., Yue, M., Wszolek, Z., Ashe, K., Knight, J., Dickson, D., Andorfer, C., Rosenberry, T. L., Lewis, J., Hutton, M., and Janus, C. (2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J. Neurosci. 27, 3650-3662 (Pubitemid 46557687)
31. Spires, T. L., Orne, J. D., SantaCruz, K., Pitstick, R., Carlson, G. A., Ashe, K. H., and Hyman, B. T. (2006) Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am. J. Pathol. 168, 1598 -1607
32. Brunden, K. R., Trojanowski, J. Q., and Lee, V. M. (2008) Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. J. Alzheimers Dis. 14, 393-399
33. Marx, J. (2007) Alzheimer's disease. A new take on tau. Science 316, 1416-1417
34. Meraz-Rios, M. A., Lira-De Leon, K. I., Campos-Pena, V., De Anda-Hernandez, M. A., and Mena-Lopez, R. (2010) Tau oligomers and aggregation in Alzheimer's disease. J. Neurochem. 112, 1353-1367
35. Kayed, R., and Jackson, G. R. (2009) Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders. Curr. Opin. Immunol. 21, 359-363
36. Santacruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., Forster, C., Yue, M., Orne, J., Janus, C., Mariash, A., Kuskowski, M., Hyman, B., Hutton, M., and Ashe, K. H. (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476 - 481
37. Sydow, A., Van der Jeugd, A., Zheng, F., Ahmed, T., Balschun, D., Petrova, O., Drexler, D., Zhou, L., Rune, G., Mandelkow, E., D'Hooge, R., Alzheimer, C., and Mandelkow, E. M. (2011) Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant. J. Neurosci. 31, 2511-2525
38. Morsch, R., Simon, W., and Coleman, P. D. (1999) Neurons may live for decades with neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 58, 188-197
39. Spires-Jones, T. L., Kopeikina, K. J., Koffie, R. M., de Calignon, A., and Hyman, B. T. (2011) Are tangles as toxic as they look? J. Mol. Neurosci. 45, 438-444
40. Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Guerrero-Muoz, M. J., Jackson, G. R., and Kayed, R. (2010) Preparation and characterization of neurotoxic tau oligomers. Biochemistry 49, 10039-10041
41. Gomez-Ramos, A., Diaz-Hernandez, M., Cuadros, R., Hernandez, F., and Avila, J. (2006) Extracellular tau is toxic to neuronal cells. FEBS Lett. 580, 4842-4850 (Pubitemid 44286844)
42. Gomez-Ramos, A., Diaz-Hernandez, M., Rubio, A., Miras- Portugal, M. T., and Avila, J. (2008) Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells. Mol. Cell. Neurosci. 37, 673- 681
43. Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Sengupta, U., Clos, A. L., Jackson, G. R., and Kayed, R. (2011) Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol. Neurodegener. 6, 39
44. Sahara, N., Maeda, S., Murayama, M., Suzuki, T., Dohmae, N., Yen, S. H., and Takashima, A. (2007) Assembly of two distinct dimers and higher-order oligomers from full-length tau. Eur. J. Neurosci. 25, 3020-3029 (Pubitemid 46888808)
45. Maeda, S., Sahara, N., Saito, Y., Murayama, S., Ikai, A., and Takashima, A. (2006) Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease. Neurosci. Res. 54, 197-201 (Pubitemid 43276078)
46. Patterson, K. R., Remmers, C., Fu, Y., Brooker, S., Kanaan, N. M., Vana, L., Ward, S., Reyes, J. F., Philibert, K., Glucksman, M. J., and Binder, L. I. (2011) Characterization of prefibrillar tau oligomers in vitro and in Alzheimers disease. J. Biol. Chem. 286, 23063-23076
47. Margittai, M., and Langen, R. (2004) Template-assisted filament growth by parallel stacking of tau. Proc. Natl. Acad. Sci. U. S. A. 101, 10278-10283 (Pubitemid 38924916)
48. Margittai, M., and Langen, R. (2006) Side chain-dependent stacking modulates tau filament structure. J. Biol. Chem. 281, 37820-37827 (Pubitemid 46042084)
49. Lasagna-Reeves, C. A., Glabe, C. G., and Kayed, R. (2011) Amyloid-β annular protofibrils evade fibrillar fate in Alzheimer's disease brain. J. Biol. Chem. 286, 22122-22130
50. Lee, V. M., Wang, J., and Trojanowski, J. Q. (1999) Purification of paired helical filament tau and normal tau from human brain tissue. Methods Enzymol. 309, 81-89 (Pubitemid 29446443)
51. o, and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J. Neurosci. 24, 4070-4081
52. Sharma, N., McLean, P. J., Kawamata, H., Irizarry, M. C., and Hyman, B. T. (2001) α-Synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies. Acta Neuropathol. 102, 329-334 (Pubitemid 32894702)
53. Knowles, R. B., Chin, J., Ruff, C. T., and Hyman, B. T. (1999) Demonstration by fluorescence resonance energy transfer of a close association between activated MAP kinase and neurofibrillary tangles: implications for MAP kinase activation in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58, 1090 -1098
54. Kinoshita, A., Whelan, C. M., Smith, C. J., Mikhailenko, I., Rebeck, G. W., Strickland, D. K., and Hyman, B. T. (2001) Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65. J. Neurosci. 21, 8354-8361 (Pubitemid 33051433)
55. Yoshida, M. (2006) Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies. Neuropathology 26, 457-470
56. Carmel, G., Mager, E. M., Binder, L. I., and Kuret, J. (1996) The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271, 32789 -32795
57. Glabe, C. G. (2008) Structural classification of toxic amyloid oligomers. J. Biol. Chem. 283, 29639-29643
58. Biernat, J., and Mandelkow, E. M. (1999) The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains. Mol. Biol. Cell 10, 727-740 (Pubitemid 29144634)
59. Goedert, M., Jakes, R., and Vanmechelen, E. (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci. Lett. 189, 167-169
60. Vidal, R., Calero, M., Piccardo, P., Farlow, M. R., Unverzagt, F. W., Mendez, E., Jimenez-Huete, A., Beavis, R., Gallo, G., Gomez-Tortosa, E., Ghiso, J., Hyman, B. T., Frangione, B., and Ghetti, B. (2000) Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-ε4 allele. Acta Neuropathol. 100, 1-12 (Pubitemid 30352862)
61. Hernandez, F., and Avila, J. (2011) Intra and extracellular protein interactions with tau. Curr. Alzheimer. Res. 7, 670-676
62. Avila, J. (2011) Intracellular and extracellular tau. Front. Neurosci. 4, 49
63. Andreasen, N., Minthon, L., Vanmechelen, E., Vanderstichele, H., Davidsson, P., Winblad, B., and Blennow, K. (1999) Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment. Neurosci. Lett. 273, 5-8 (Pubitemid 29415689)
64. Galasko, D., Clark, C., Chang, L., Miller, B., Green, R. C., Motter, R., and Seubert, P. (1997) Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology 48, 632-635 (Pubitemid 27120097)
65. Blom, E. S., Giedraitis, V., Zetterberg, H., Fukumoto, H., Blennow, K., Hyman, B. T., Irizarry, M. C., Wahlund, L. O., Lannfelt, L., and Ingelsson, M. (2009) Rapid progression from mild cognitive impairment to alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOEε4/ε4 Genotype. Dement. Geriatr. Cogn. Disord. 27, 458-464
66. Shaw, L. M., Vanderstichele, H., Knapik-Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., Dean, R., Siemers, E., Potter, W., Lee, V. M., and Trojanowski, J. Q. (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann. Neurol. 65, 403-413
67. Sengupta, A., Kabat, J., Novak, M., Wu, Q., Grundke-Iqbal, I., and Iqbal, K. (1998) Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch. Biochem. Biophys. 357, 299-309 (Pubitemid 28419212)
68. Cho, J. H., and Johnson, G. V. (2004) Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3β (GSK3β) plays a critical role in regulating tau's ability to bind and stabilize microtubules. J. Neurochem. 88, 349-358
69. Lin, Y. T., Cheng, J. T., Liang, L. C., Ko, C. Y., Lo, Y. K., and Lu, P. J. (2007) The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3β. J. Neurochem. 103, 802- 813
70. Jicha, G. A., Lane, E., Vincent, I., Otvos, L., Jr., Hoffmann, R., and Davies, P. (1997) A conformation- and phosphorylationdependent antibody recognizing the paired helical filaments of Alzheimer's disease. J. Neurochem. 69, 2087-2095 (Pubitemid 27452756)
71. Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., and Wisniewski, H. M. (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 477, 90 -99
72. Uchihara, T., Nakamura, A., Yamazaki, M., and Mori, O. (2001) Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol. 101, 535-539 (Pubitemid 32684750)
73. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356 (Pubitemid 34790756)
74. Selkoe, D. J. (1994) Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53, 438-447
75. Braak, H., and Braak, E. (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351-357 (Pubitemid 27435070)
76. Braak, H., and Del Tredici, K. (2011) The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol. 121, 171-181
77. Small, S. A., and Duff, K. (2008) Linking Aβ and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 60, 534-542
78. Duyckaerts, C. (2011) Tau pathology in children and young adults: can you still be unconditionally baptist? Acta Neuropathol. 121, 145-147
79. Haass, C., and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid betapeptide. Nat. Rev. Mol. Cell Biol. 8, 101-112 (Pubitemid 46432529)
80. Caughey, B., Baron, G. S., Chesebro, B., and Jeffrey, M. (2009) Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu. Rev. Biochem. 78, 177-204
81. Glabe, C. G. (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging 27, 570-575
82. Oddo, S., Vasilevko, V., Caccamo, A., Kitazawa, M., Cribbs, D. H., and LaFerla, F. M. (2006) Reduction of soluble Aβ and tau, but not soluble Aβ alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J. Biol. Chem. 281, 39413-39423 (Pubitemid 46041901)
83. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., and Ashe, K. H. (2006) A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357
84. Rostagno, A., and Ghiso, J. (2009) Isolation and biochemical characterization of amyloid plaques and paired helical filaments. Curr. Protoc. Cell Biol. Chapter 3, Unit 3.33, 1-33
85. Campioni, S., Mannini, B., Zampagni, M., Pensalfini, A., Parrini, C., Evangelisti, E., Relini, A., Stefani, M., Dobson, C. M., Cecchi, C., and Chiti, F. (2011) A causative link between the structure of aberrant protein oligomers and their toxicity. Nat. Chem. Biol. 6, 140-147
86. Kayed, R., Canto, I., Breydo, L., Rasool, S., Lukacsovich, T., Wu, J., Albay, R., 3rd, Pensalfini, A., Yeung, S., Head, E., Marsh, J. L., and Glabe, C. (2010) Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers. Mol. Neurodegener. 5, 57
87. Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., Rasool, S., Gurlo, T., Butler, P., and Glabe, C. G. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18
88. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., and Hyman, B. T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639
89. Braak, E., Braak, H., and Mandelkow, E. M. (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 87, 554-567 (Pubitemid 24158408)
90. Kimura, T., Ono, T., Takamatsu, J., Yamamoto, H., Ikegami, K., Kondo, A., Hasegawa, M., Ihara, Y., Miyamoto, E., and Miyakawa, T. (1996) Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments. Dementia 7, 177-181
91. Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., Jucker, M., Goedert, M., and Tolnay, M. (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909-913
92. Frost, B., and Diamond, M. I. (2010) Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 11, 155-159
93. Brundin, P., Melki, R., and Kopito, R. (2010) Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat. Rev. Mol. Cell Biol. 11, 301-307
94. Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., and Powell, T. P. (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 82, 4531-4534 (Pubitemid 15233154)
95. Delacourte, A., Sergeant, N., Wattez, A., Maurage, C. A., Lebert, F., Pasquier, F., and David, J. P. (2002) Tau aggregation in the hippocampal formation: an ageing or a pathological process? Exp. Gerontol. 37, 1291-1296 (Pubitemid 35418288)
96. Lace, G., Savva, G. M., Forster, G., de Silva, R., Brayne, C., Matthews, F. E., Barclay, J. J., Dakin, L., Ince, P. G., and Wharton, S. B. (2009) Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. Brain 132, 1324-1334
97. Ciechanover, A., Orian, A., and Schwartz, A. L. (2000) Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays 22, 442-451 (Pubitemid 30308270)
98. Dickey, C. A., Yue, M., Lin, W. L., Dickson, D. W., Dunmore, J. H., Lee, W. C., Zehr, C., West, G., Cao, S., Clark, A. M., Caldwell, G. A., Caldwell, K. A., Eckman, C., Patterson, C., Hutton, M., and Petrucelli, L. (2006) Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. J. Neurosci. 26, 6985-6996 (Pubitemid 44309866)
99. Cripps, D., Thomas, S. N., Jeng, Y., Yang, F., Davies, P., and Yang, A. J. (2006) Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. J. Biol. Chem. 281, 10825-10838 (Pubitemid 43855505)